Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Product Defects Appear in Second Skincare Brand at P&G Plant [PG,ACV]

|Includes: ACV-OLD, The Procter & Gamble Company (PG)

In May we commented on the scorching warning letter FDA sent to P&G alleging product defects and quality assurance failures in its Olay skincare line [FDA’s Warning Letter Excoriates P&G; Sugges....].  Unexpectedly and independent of that action Alberto-Culver hasNoxzema filed suit last week against P&G in Chancery Court in Illinois alleging that product defects are evident in the Noxzema brand sold to it by P&G in 2008.  P&G is also their current contract manufacturer.  Culver is claiming breach of contract and failure to disclose among other contentions.  As noted in our recent commentary on Olay the P&G Puerto Rico manufacturing site has a history of quality control failures dating back decades to when Richardson-Vicks owned it.  Not surprisingly Noxzema is manufactured at this same site.   Read the full story at: